New cardiovascular risk guidelines in the U.S. are shifting how doctors classify patient health, moving away from race-based formulas toward more personalized metrics. Research published in JAMA, led by Allison Peng, MD, of the Johns Hopkins University School of Medicine, indicates that 22% of adults will change risk categories under the new PREVENT-atherosclerotic cardiovascular disease … Read more
The prevalence of GLP-1 drugs for weight loss among U.S. adults has reached a record high, with 11% of the population currently using medications like Ozempic and Wegovy, according to a Gallup survey of 5,065 adults conducted between May 28 and June 5. This surge correlates with a decline in the national obesity rate, which … Read more
Lactoferrin-fortified yogurt maintains ferritin levels in pregnant women with gestational diabetes mellitus (GDM) without causing iron overload, according to a randomized trial published in npj Science of Food. The study found that 100 mg of bovine lactoferrin per serving helped stabilize iron stores in women with reduced ferritin, offering a well-tolerated alternative to relying solely … Read more
Genetic Insights into GLP-1R and Mental Health Genetic evidence suggests that lifelong activation of the glucagon-like peptide-1 receptor (GLP-1R) may reduce risks of major depressive disorder (MDD) and bipolar disorder (BD), according to a study published in Translational Psychiatry. Researchers used Mendelian randomization (MR) to analyze data from genome-wide association studies (GWASs), linking genetic variants … Read more
Metabolic dysfunction-associated steatotic liver disease (MASLD) may affect up to 47% of adults in Mexico, according to a review published in Archives of Medical Research. Lead author Jeffrey Lazarus, a professor at the CUNY Graduate School of Public Health and Health Policy, argues that Mexico must integrate liver health into existing obesity and diabetes programs … Read more
Researchers at Ruhr University Bochum, in collaboration with the Heart and Diabetes Center NRW, have identified that the hepatitis E virus (HEV) undergoes dynamic genetic evolution during the initial weeks of infection. According to a study published in mBio on July 10, 2026, scientists observed recurring mutations in the viral polymerase gene, even within patients … Read more
A systematic review published in Scientific Reports found no statistically significant increase in major congenital malformations, stillbirths, or preterm births following maternal exposure to GLP-1 receptor agonists. While the data offers “cautious reassurance” for inadvertent exposure, researchers state the evidence certainty remains low, meaning these medications are not yet considered safe for routine use during … Read more
Average total testosterone levels in men dropped by 54 percent between 1972 and 2019, according to a multi-country analysis presented at the European Society of Human Reproduction and Embryology. Led by Prof. Hagai Levine of the Hebrew University-Hadassah Braun School of Public Health and Community Medicine, the research synthesized six longitudinal studies involving 118,593 men … Read more
Medicare prescriptions for the anti-obesity medication Wegovy surged 598% in the six months following a federal policy shift that allowed coverage for heart disease prevention. Despite this increase, new research from the USC Schaeffer Center for Health Policy & Economics reveals that less than 1% of the estimated 3.6 million eligible beneficiaries have accessed the … Read more
Adults with coronary heart disease (CHD) who follow diets supporting gut microbiota health may face a lower risk of all-cause mortality, according to a retrospective cohort analysis published in the journal Medicine. Researchers using NHANES data (2005–2018) found that participants with the highest Dietary Index for Gut Microbiota (DI-GM) scores had significantly lower death rates … Read more